OCEANSIDE, N.Y.--(BUSINESS WIRE)--elliquence, LLC., a leading medical device designer and manufacturer based in Oceanside, New York, and Bonovo Orthopedics, Inc., a premier developer, manufacturer and distributor of orthopedic and neurosurgical products to the Chinese community, have partnered to distribute elliquence products in China. Headquartered in the United States, Bonovo maintains operations in Beijing, Shanghai and Tianjin, and has distribution offices throughout China.

According to Peter Slate, Chief Executive Officer of Bonovo, “Our partnership with elliquence furthers Bonovo’s commitment to bring the latest minimally invasive products to the Chinese orthopedic and neurosurgical markets. Partnering with innovative partners like elliquence has become a growing component of Bonovo’s business.”

Committed to driving new standards of premium orthopedic care, the Bonovo team will now distribute elliquence products including elliquence’s proprietary energy source, the Patented Surgi-Max®. Emitting high radiofrequency, low-temperature radio waves, the Surgi-Max® enables surgeons to perform delicate, minimally invasive surgery with unparalleled precision, versatility and safety. Bonovo has further enhanced its product portfolio to also include elliquence’s acclaimed Trigger-Flex® Bipolar System (featured in Disc-FX®). Disc-FX rapidly and effectively performs minimally invasive discectomy procedures for contained lumbar spine herniations.

Alan Ellman, Chief Executive Officer of Elliquence, states, "Bonovo Orthopedics is the perfect partner for elliquence’s unique, patented minimally invasive products and we are excited about the potential this relationship offers the patients and physicians in the orthopedic and neurosurgical markets."

About elliquence, LLC.

elliquence, LLC. is a privately held, ISO certified company, which designs, manufactures and markets a wide range of innovative, high frequency products for enhanced surgical procedures. elliquence celebrates its extraordinary lineage; a 50 year heritage of technological distinction and global presence in the fields of neurosurgery, endoscopic spine, orthopedic and pain management. The company’s vision has been to partner with the medical community to develop high quality, cost-effective products benefiting patients, doctors and medical facilities. Focusing to improve upon surgical intervention by way of ‘healthy tissue preservation,’ elliquence promotes less trauma, minimized scar tissue formation, reduced post-operative pain and an early return to a productive lifestyle. For more information on elliquence and its products visit www.elliquence.com

About Bonovo Orthopedics

Bonovo Orthopedics, Inc. is a premier developer, manufacturer and distributor of orthopedic implants and other products to the orthopedic and neurosurgical markets. Bonovo has been a leader in the Chinese orthopedic industry for over 15 years. Bonovo distributes its own products, and serves as a distribution partner for other leading international companies. The Bonovo team is committed to driving new standards of orthopedic care throughout China by bringing the best products to market – products that combine strong market demand with great social benefit. For more information on Bonovo and its products visit www.bonovo-ortho.com.